Drug-eluting stents vs bare metal stents for the treatment of large coronary vessels

American Heart Journal

Volumn 154, Issue 2, 2007, Pages 373-378

  Quizhpe, Arturo R ^a   Feres, Fausto ^a   de Ribamar Costa Jr , José ^a   Abizaid, Alexandre ^a   Maldonado, Galo ^b   Costa, Ricardo ^a   Abizaid, Andrea ^a   Cano, Manuel ^b   Moreira, Adriana C ^b   Staico, Rodolfo ^a   Mattos, Luiz Alberto ^a   Tanajura, Luiz Fernando ^a   Chaves, Aurea ^a   Centemero, Marinella ^a   Sousa, Amanda M R ^a,b   Sousa, J Eduardo M R ^a,b  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^b Hospital do Coracao   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY OBSTRUCTION; CORONARY STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART DEATH; HEART MUSCLE REVASCULARIZATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY STENOSIS; CORONARY VESSELS; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PACLITAXEL; SIROLIMUS; STENTS;

EID: 34447571734     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.027     Document Type: Article

References (22)

1. Foley D.P., Melekert R., and Serruys P.W. Influence of coronary vessel size on renarrowing process and late angiographic outcome after successful balloon angioplasty. Circulation 90 (1994) 1239-1251
2. Elezi S., Kastrati A., Neumann F.J., et al. Vessels size and long-term outcome after coronary stent placement. Circulation 98 (1998) 1875-1880
3. Serruys P, Kay P, Disco C. et al. Periprocedural Quantitative coronary angiography after Palmaz-Schatz stent implantation predicts the restenosis rate at six months: results of a meta-analysis of the Belgian Netherlands stent study (BESTENT) I, BESTENT II pilot, BESTENT II and MUSIC trials.
4. Hirshfeld Jr. J.W., Schwartz J.S., Jugo R., et al. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis. J Am Coll Cardiol 18 (1991) 647-656
5. Stone G.W., Ellis S.G., Cox D.A., et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
6. Stone W., Ellis S., Cannon L., et al. Comparison of a polymer-based paclitaxel-eluting stent with a bare metal stent in patients with complex coronary artery disease. A randomized controlled trial (TAXUS V) trial. JAMA 294 (2005) 1215-1223
7. Sousa J.E., Costa M.A., Abizaid A., et al. Lack of neointimal proliferation after implantation of sirolimus-coated stents in human coronary arteries: a quantitative coronary angiography and three-dimensional intravascular ultrasound study. Circulation 103 (2001) 192-195
8. Schofer J., Schluter M., Gershlick A.H., et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS). Lancet 362 (2003) 1093-1099
9. Schampaert E., Cohen E.A., Schluter M., et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS). J Am Coll Cardiol 43 (2004) 1110-1115
10. Dibra A., Kastrati A., Mehilli J., et al. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 353 (2005) 663-670
11. Akiyama T., Moussa I., Reimers B., et al. Angiographic and clinical outcomes following coronary artery stenting of small vessels: a comparison with coronary stenting of large vessels. J Am Coll Cardiol 98 (1998) 1610-1618
12. Mintz G.S., Kent K.M., Pichard A.D., et al. Contribution of inadequate arterial remodeling to the development of focal coronary artery stenosis: an intravascular ultrasound study. Circulation 95 (1997) 1791-1799
13. Hoffmann R., Mintz G.S., Dussaillant G.R., et al. Patterns and mechanisms of in-stent restenosis: a serial intravascular ultrasound study. Circulation 94 (1996) 1247-1254
14. Morice M.C., Serruys P.W., Sousa J.E., et al. Randomized study with the sirolimus-coated Bx velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
15. Stone G.W., Ellis S.G., Cox D.A., et al. One-year clinical results with slow-release, polymer-based, paclitaxel-eluting TAXUS stent: TAXUS-IV trial. Circulation 109 (2004) 1942-1947
16. Pache J., Dibra A., Mehilli J., et al. Drug-eluting stents compared with thin-strut bare metal stents for the reduction of restenosis: a prospective, randomized trial. Eur Heart J 26 (2005) 1262-1268
17. Ellis S.G., Popma J.J., Lasala J.M., et al. Relationship between angiographic late loss and target lesion revascularization after coronary stent implantation. Analysis from TAXUS-IV trial. J Am Coll Cardiol 45 (2005) 1193-1200
18. Kastrati A., Mehilli J., Dirschinger J., et al. Restenosis after coronary placement of various stents types. Am J Cardiol 87 (2001) 34-39
19. Kastrati A., Mehilli J., Dirschinger J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. Circulation 103 (2001) 2816-2821
20. Kastrati A., Mehilli J., Dirschinger J., et al. Intracoronary stenting and angiographic results: strut thickness effect on restenosis outcome (ISAR-STEREO) trial. J Am Coll Cardiol 41 (2003) 1283-1288
21. Steinberg D.H., Mishra S., Javaid A., et al. Comparison of effectiveness of bare metal stents versus drug-eluting stents in large (> or =3.5 mm) coronary arteries. Am J Cardiol 99 (2007) 599-602
22. van Hout B.A., Serruys P.W., Lemos P.A., et al. One year cost effectiveness of sirolimus eluting stents compared with bare metal stents in the treatment of single native de novo coronary lesions: an analysis from the RAVEL trial. Heart 91 (2005) 507-512